Status: Recruiting
Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection
This is an multicenter study that will test the diagnostic accuracy of a blood test (i.e., a liquid biopsy) for the diagnosis of colorectal cancer (CRC), advanced adenomas (AAs), as well as Lynch-syndrome associated cancers. Additionally, a pre-planned analysis will evaluate the use of this liquid biopsy as a tool for molecular residual disease monitoring purposes.
Participants needed: 1,200
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: San Raffaele UniversityUpdated: Mar 4, 2026Locations: 4
Eligibility criteria
All individuals included in the study need to have had a colonoscopy at the time... [+2]
Lack of informed consent [+1]